
Docefect-RTU 120mg Injection
Marketer
Aureate Healthcare Pvt Ltd
Salt Composition
Docetaxel (120mg)
Overview Docefect-RTU 120mg Injection
Docef-RTU 120mg injectable solution is a chemotherapy agent indicated for treating breast, non-small cell lung, prostate, and head and neck cancers. Administration is exclusively by intravenous injection under the supervision of a qualified healthcare professional. Dosage and frequency are determined individually by your oncologist based on your specific condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for several weeks or months; discontinue use only under your physician's direction. Common side effects include shortness of breath, constipation, swelling, infections, decreased appetite, myalgia, nail abnormalities, pain, and fatigue. Your doctor might prescribe supportive medications to mitigate these. Report any unusual bruising, bleeding, sore throat, mouth sores, or fever promptly. This medication can lower blood cell counts (including red and white blood cells), increasing infection risk. Regular blood tests to monitor blood cell levels and liver function are essential. Prior to commencing treatment, inform your physician of any pre-existing cardiac, hepatic, or renal conditions, as well as all other medications, including antibiotics, you are currently taking, as drug interactions are possible. This medication is contraindicated during pregnancy and lactation. Reliable contraception is mandatory for both partners throughout the treatment period to prevent conception.
Uses of Docefect-RTU 120mg Injection
Cancers of the breast, lung (non-small cell), prostate, and head and neck.
Major Benefits of Docefect-RTU 120mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Docefect-RTU 120mg Injection:
- Breathlessness
- Constipation
- Edema (swelling)
- Infection
- Loss of appetite
- Muscle pain
- Nail disorder
- Pain
- Weakness
How to use Docefect-RTU 120mg Injection:
Administering this medication will be done by your physician or their qualified assistant; self-medication is strictly prohibited.
How Docefect-RTU 120mg Injection works:
Docefect-RTU 120mg Injection is a medication used in cancer treatment. Its mechanism of action involves disrupting microtubules, essential components in cancer cell division. This disruption inhibits cancer cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Docefect-RTU 120mg Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Docefect-RTU 120mg Injection during pregnancy poses a confirmed risk to the fetus. Its use is therefore contraindicated, except in exceptional, life-threatening circumstances where the potential benefits clearly outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Docefect-RTU 120mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates the medication may harm the nursing infant.
DrivingCONSULT YOUR DOCTOR
The impact of Docefect-RTU 120mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you encounter any symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Docefect-RTU 120mg Injection presents no need for dosage modification in individuals with impaired renal function and is considered safe for their use.
LiverCAUTION
Exercise caution when administering Docefect-RTU 120mg Injection to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Docefect-RTU 120mg Injection :
NA
Facts to Know About Docefect-RTU 120mg Injection
| Label | Value |
|---|---|
| Pharmaceutical Classification | Taxane-based compounds |
| Potential for Dependence | None. |
| Type of Medication | Cancer-fighting medications |
| Mechanism of Action | Microtubule-disrupting drugs: Taxane class |
